| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.593 | 16.602 | 7.289 | 9.130 | 6.912 | 7.064 |
| Total Income - EUR | - | - | - | - | 6.852 | 19.404 | 12.829 | 12.477 | 10.228 | 10.362 |
| Total Expenses - EUR | - | - | - | - | 15.463 | 30.263 | 12.363 | 10.886 | 9.777 | 9.439 |
| Gross Profit/Loss - EUR | - | - | - | - | -8.611 | -10.859 | 465 | 1.590 | 451 | 923 |
| Net Profit/Loss - EUR | - | - | - | - | -8.611 | -10.979 | 180 | 1.322 | 379 | 775 |
| Employees | - | - | - | - | 3 | 3 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - C&I Infusion S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 19.930 | 27.356 | 23.433 | 20.179 | 16.782 | 13.390 |
| Current Assets | - | - | - | - | 10.910 | 2.225 | 2.167 | 1.775 | 1.998 | 5.104 |
| Inventories | - | - | - | - | 0 | 778 | 760 | 763 | 0 | 0 |
| Receivables | - | - | - | - | 9.395 | 874 | 854 | 857 | 854 | 178 |
| Cash | - | - | - | - | 1.514 | 574 | 553 | 155 | 1.144 | 4.926 |
| Shareholders Funds | - | - | - | - | -8.569 | -19.386 | -18.776 | -17.513 | -17.081 | -16.210 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 8.679 | 21.621 | 20.954 | 19.297 | 19.070 | 21.306 |
| Income in Advance | - | - | - | - | 30.730 | 27.345 | 23.422 | 20.168 | 16.790 | 13.398 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9622 - 9622" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - C&I Infusion S.r.l.